IKT Latest Press Releases

-- October 27, 2026 --

Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026 Globe Newswire 8:00 AM

-- October 20, 2026 --

Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors Globe Newswire 4:01 PM

-- October 2, 2026 --

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- August 11, 2026 --

Inhibikase Therapeutics Announces Second Quarter 2026 Financial Results and Highlights Recent Activity Globe Newswire 4:01 PM

-- July 23, 2026 --

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH Globe Newswire 8:00 AM

-- July 14, 2026 --

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility Globe Newswire 8:00 AM

-- July 2, 2026 --

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

Market Data Delayed 15 Minutes